Pharma Journalist - Page 66 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

WuXi Biologics Begins Construction of Chengdu Microbial Manufacturing Facility

Cellectar Receives FDA Breakthrough Designation for Iopofosine in WM

Vividion and Bayer Advance Oncology Pipeline with Clinical-Stage WRN Inhibitor

Camurus and Lilly Partner on Long-Acting FluidCrystal Incretins

SpyGlass Pharma Raises $75M to Advance Glaucoma Drug Delivery Platform

EU Approves Roche’s Evrysdi as First Oral Treatment for SMA

Agenus, Zydus Ink $141M Deal to Advance BOT/BAL, Expand U.S. Biologics Production

FDA Approves NUBEQA for Metastatic Prostate Cancer

EU Approves ADCETRIS Combo for Newly Diagnosed Advanced Hodgkin Lymphoma

Regeneron Boosts Obesity Pipeline with Dual GLP-1/GIP Agonist Deal